autoinjector devices therapeutics market data   Autoinjector Devices Therapeutics Market Data  •  Published June 2017  •  Catalog no. AJR884F  •  Price US $3,850


In the past five years, autoinjectors – pen-like devices that can accept standard prefilled syringes and simplify the injection event for patients – have emerged as a major drug delivery platform. The number of drugs available in prefilled syringes as a percentage of all injectable drugs continues to grow. So too does the number of injectable drugs indicated for chronic conditions and self-administration. But suppliers of autoinjectors face several challenges as the market evolves and matures. Continued interest in plastic prefilled syringes will require non-brand specific injector manufacturers to validate that their devices function consistently and safely over the range of these emerging PFS devices – devices with rigidity, barrel lubricity and flexural properties that differ not insignificantly from type 1 glass. They will have to compete – in some cases head-on – with prefilled syringe suppliers, who are increasingly incorporating autoinjector-like ease-of-use features into their PFS designs to differentiate their product lines and in some cases to meet their pharma customer requirements for product-specific syringe designs.

Bar_Graph    Autoinjector Devices Report Brochure (Download PDF)

Blue document
Autoinjector Devices Report Order Form (Download PDF)

 


Autoinjector Devices Therapeutics Market Data – What You Will Learn

• What autoinjectors can be paired with prefilled syringes for injectable drug delivery; what are the key market segments, market dynamics and market demographics?
• What are the therapeutic demand drivers and commercial devices in key product segments?
• What are the design factors, material selection issues, technologies and market development issues?
• How big is the market? How is it growing? What will it look like in 2024?
• Who are the leading injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations?
• What is the importance of pharma-device alliances and design partnerships on autoinjector commercialization and market access?
• What is the impact of wirelessly connected autoinjectors on patient care and market growth?
• What are the significant economic, technology, and regulatory factors affecting the market for autoinjectors?


Autoinjector Devices Therapeutics Market Data – Summary of Contents

Executive Summary

The Market Opportunity
Delivery Market Dynamics
The Economics of Injectable Drugs
What’s Driving the Growth in Autoinjectors?
Prefilled Syringes Proliferating
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors

Autoinjectors – Commercial Devices
Manual Injection Autoinjectors
Automated Injection Autoinjectors
Reusable Autoinjectors
Disposable Autoinjectors
Variable Dose Autoinjectors
Product Specific Autoinjectors

Autoinjector Device Design Factors
Material Selection Issues
Part Counts and Device Cost
Safety Features
Needle Shielding
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Lyophilized Drugs/Reconstitution
Human Engineering/Ergonomics

Autoinjector Drug Delivery – Key Therapeutic Sector Analysis
Anticoagulants
Autoimmune Diseases
Rheumatoid Arthritis
Multiple Sclerosis
Psoriasis
Emergency Medicine
Epipen
Hepatitis
Hematopoietics
Hormones
Reproductive Health

Market Factors
Regulatory Issues
Device Branding
Patient Compliance and Ease of Use
Healthcare Economics

Company Profiles

 

Comments or questions?

* indicates required field

Useful Links

Injectors for Special Populations